Ligand validation:3GSP

SGP: GUANOSINE-2',3'-CYCLOPHOSPHOROTHIOATE

SGP is a Ligand Of Interest in 3GSP designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3GSP_SGP_A_105	56%	30%	0.144	0.914	1.36	1.42	4	4	2	0	100%	0.4
7GSP_SGP_A_107	81%	31%	0.088	0.939	1.68	1.07	5	2	0	0	100%	1
4GSP_SGP_A_106	57%	21%	0.126	0.899	1.86	1.46	5	3	3	0	100%	0.35
2GSP_SGP_A_105	25%	38%	0.198	0.831	1.47	0.97	6	1	5	0	100%	0.6
1GSP_SGP_A_105	13%	31%	0.211	0.753	1.24	1.5	3	3	2	0	100%	1
1RSN_SGP_A_97	95%	10%	0.074	0.976	1.7	2.53	3	7	0	0	100%	1
3D5I_SGP_B_98	34%	18%	0.184	0.867	1.95	1.58	3	4	2	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.